To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MCM3APTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
403 representative clones for gene MCM3AP back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI195673 brain, neuroblastoma .a 1 to 514 1 to 514   tiling clone,   514/514
(100 %)
4 diff
(99.3 %id)
AL079407 testis .a 122 to 617 1 to 496   tiling clone, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 496/496
(100 %)
0 diff
(100 %id)
BF988364 placenta_normal .a 287 to 876 613 to 25       589/632
(93 %)
6 diff
(99.1 %id)
BF990835 placenta_normal .a 287 to 876 619 to 32       588/631
(93 %)
4 diff
(99.4 %id)
TI_1241111761   .a 506 to 1117 616 to 3       614/723
(84 %)
0 diff
(100 %id)
BC104958 Brain, PCR rescued clones .a 519 to 6562 1 to 6044 S102L tiling clone,   6044/6044
(100 %)
2 diff
(100.0 %id)
BC104960 Brain, PCR rescued clones .a 519 to 6555 1 to 6037 S102L     6037/6037
(100 %)
2 diff
(100.0 %id)
AJ010089   .a 558 to 6671 1 to 6114 exact tiling clone,   6114/6114
(100 %)
3 diff
(100.0 %id)
NM_003906.3   .a 559 to 6671 1 to 6113 exact RefSeq,   6113/6113
(100 %)
0 diff
(100 %id)
DA568738 whole embryo, mainly head .a 649 to 1405 2 to 758   capped   757/757
(100 %)
1 diff
(99.9 %id)
TI_1241111749   .a 682 to 1395 722 to 8       715/722
(99 %)
0 diff
(100 %id)
TI_1241109857   .a 846 to 2038 1217 to 24       1194/1301
(91 %)
42 diff
(96.8 %id)
AB011144 brain .a 917 to 6671 1 to 5755   available from KIAA,   5755/5755
(100 %)
2 diff
(100.0 %id)
BU165571 eye, retinoblastoma .a 1091 to 1998 1 to 920       920/921
(99 %)
15 diff
(98.4 %id)
DB092001 testis .a 1108 to 1659 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA248605 brain .a 1181 to 1778 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
CR978576 T-Lymphocytes .a 1267 to 2169 1 to 905       905/906
(99 %)
10 diff
(98.9 %id)
CR994559 T-Lymphocytes .a 1267 to 2168 1 to 902       902/902
(100 %)
2 diff
(99.8 %id)
BI858194 breast, mammary adenocarcinoma, cell line .a 1276 to 2025 1 to 751       751/752
(99 %)
5 diff
(99.4 %id)
TI_57187166   .a 1276 to 2025 52 to 802       751/752
(99 %)
5 diff
(99.4 %id)
TI_1241109875   .a 1318 to 2419 1100 to 1       1100/1231
(89 %)
12 diff
(99.1 %id)
DA791369 brain .a 1496 to 2125 2 to 631   capped   630/630
(100 %)
0 diff
(100 %id)
AK304208 trachea .a 1628 to 6671 1 to 5044       5044/5044
(100 %)
6 diff
(99.9 %id)
TI_1241109855   .a 1628 to 2725 1117 to 11       1107/1230
(90 %)
25 diff
(98.0 %id)
DA413457 thalamus .a 1636 to 2194 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BE408038 choriocarcinoma, placenta .a 1701 to 2458 1 to 762       762/806
(94 %)
23 diff
(97.2 %id)
CN419357 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1808 to 2489 1 to 683       684/683
(100 %)
5 diff
(99.3 %id)
DB064283 testis .a 1992 to 2533 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
BE771177 prostate_tumor .a 2075 to 2448 386 to 13       374/386
(96 %)
0 diff
(100 %id)
AW602037 breast .a 2124 to 2310 190 to 5       186/198
(93 %)
1 diff
(99.5 %id)
BM548923 duodenal adenocarcinoma, cell line, small intestine .a 2141 to 3150 1 to 1015       1015/1058
(95 %)
46 diff
(95.7 %id)
BE771202 prostate_tumor .a 2163 to 2433 298 to 13       286/298
(95 %)
9 diff
(97.0 %id)
CK023651 brain/CNS, Bulk tissue from Human Spinal cord .a 2269 to 2949 1 to 676       676/747
(90 %)
13 diff
(98.3 %id)
TI_1241109873   .a 2341 to 3298 963 to 10       954/1208
(78 %)
17 diff
(98.6 %id)
DA329816 hippocampus .a 2439 to 3006 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BU557007 ovary, teratocarcinoma, cell line .a 2553 to 3462 1 to 921       921/949
(97 %)
15 diff
(98.5 %id)
BQ354192 head_neck .a 2561 to 2975 428 to 10       419/428
(97 %)
3 diff
(99.3 %id)
DA326052 hippocampus .a 2565 to 3074 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
DA754344   .a 2571 to 3125 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
TI_1241109871   .a 2642 to 3626 986 to 3       984/1268
(77 %)
8 diff
(99.4 %id)
BU194359 adenocarcinoma, Pancreas .a 2667 to 3572 1 to 912       912/929
(98 %)
19 diff
(98.0 %id)
BU188793 adenocarcinoma, Pancreas .a 2667 to 3383 1 to 720       720/966
(74 %)
9 diff
(99.1 %id)
BG575156 breast, mammary adenocarcinoma, cell line .a 2743 to 3550 7 to 816       810/818
(99 %)
17 diff
(98.0 %id)
DA725077   .a 2814 to 3376 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BM806666 melanotic melanoma, skin .a 2831 to 3780 1 to 963       963/1070
(90 %)
28 diff
(97.4 %id)
CD654210 Embryonic Stem cells .a 2890 to 3634 10 to 756       747/797
(93 %)
16 diff
(98.0 %id)
TI_154161112   .a 2903 to 3603 80 to 768       689/694
(99 %)
33 diff
(95.3 %id)
DA689644   .a 2930 to 3473 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
EC449797 Prostate .a 2967 to 3068 109 to 8       102/109
(93 %)
0 diff
(100 %id)
AL527136 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2983 to 3929 19 to 958       940/1050
(89 %)
17 diff
(98.4 %id)
BQ231535 melanotic melanoma, skin .a 2995 to 3829 1 to 835       835/874
(95 %)
9 diff
(99.0 %id)
BQ926486 large cell carcinoma, lung .a 3016 to 3976 25 to 984       960/984
(97 %)
32 diff
(96.8 %id)
BM473114 duodenal adenocarcinoma, cell line, small intestine .a 3023 to 3834 5 to 817       813/1017
(79 %)
10 diff
(99.1 %id)
CN419355 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3072 to 3745 1 to 674       674/674
(100 %)
2 diff
(99.8 %id)
DA725437   .a 3143 to 3697 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA370383 thalamus .a 3159 to 3654 2 to 497   capped   496/496
(100 %)
0 diff
(100 %id)
DA247906 brain .a 3259 to 3833 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA438444 tongue, tumor tissue .a 3287 to 3843 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
TI_1241109869   .a 3383 to 4333 962 to 13       950/1178
(80 %)
4 diff
(99.7 %id)
BI091359 cervix .a 3398 to 4322 1 to 926       926/927
(99 %)
20 diff
(97.9 %id)
BE891336 melanotic melanoma, skin .a 3403 to 4103 1 to 697       697/704
(99 %)
6 diff
(99.2 %id)
DA797074 brain .a 3408 to 3872 2 to 466   capped   465/465
(100 %)
0 diff
(100 %id)
CA489052   .a 3422 to 4310 1 to 899       899/912
(98 %)
19 diff
(98.0 %id)
DA726647   .a 3429 to 3959 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA755836   .a 3456 to 4037 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BX479928   .a 3504 to 4139 1 to 635       635/635
(100 %)
4 diff
(99.4 %id)
DA697633   .a 3505 to 4027 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
DA741839   .a 3505 to 4039 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
BQ707525 Spleen .a 3513 to 4329 1 to 829       829/922
(89 %)
15 diff
(98.4 %id)
BQ706747 Spleen .a 3513 to 4329 1 to 824       824/880
(93 %)
30 diff
(96.6 %id)
BQ708909 Spleen .a 3513 to 4329 1 to 820       820/869
(94 %)
10 diff
(98.9 %id)
DA020932   .a 3520 to 4034 2 to 516   capped   515/515
(100 %)
0 diff
(100 %id)
DB137665 thymus .a 3553 to 4103 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB076784 testis .a 3562 to 4027 2 to 467   capped   466/466
(100 %)
0 diff
(100 %id)
BQ927814 large cell carcinoma, lung .a 3577 to 4394 1 to 821       821/955
(85 %)
5 diff
(99.5 %id)
BQ935550 large cell carcinoma, lung .a 3577 to 4496 1 to 926       926/932
(99 %)
23 diff
(97.6 %id)
DA172680 amygdala .a 3752 to 4318 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BX370655   .a 3777 to 4670 1 to 888       888/888
(100 %)
9 diff
(99.0 %id)
CN419352 embryonic stem cells, cell lines H1, H7, andH9 .a 3789 to 4415 1 to 627       627/627
(100 %)
2 diff
(99.7 %id)
DA794260 brain .a 3820 to 4292 2 to 474   capped   473/473
(100 %)
0 diff
(100 %id)
DA025884   .a 3822 to 4382 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
TI_1241109849   .a 3827 to 4901 1093 to 18       1076/1163
(92 %)
12 diff
(99.0 %id)
AW894490 nervous_normal .a 3872 to 4176 337 to 31       307/351
(87 %)
2 diff
(99.5 %id)
DA267777 caudate nucleus .a 3934 to 4448 2 to 516   capped   515/515
(100 %)
0 diff
(100 %id)
BG827938 muscle, rhabdomyosarcoma .a 3975 to 4705 1 to 734       734/734
(100 %)
13 diff
(98.3 %id)
DA103930 cerebellum .a 3983 to 4519 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BE906050 epithelioid carcinoma, Pancreas .a 4002 to 4651 1 to 648       648/648
(100 %)
2 diff
(99.7 %id)
AL701215 human skeletal muscle .a 4014 to 4576 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BQ889886 brain, neuroblastoma, cell line .a 4015 to 4949 1 to 940       940/941
(99 %)
16 diff
(98.3 %id)
CX786901 human embryonic stem cells .a 4024 to 4721 1 to 698       698/698
(100 %)
2 diff
(99.8 %id)
CF780747 Pooled Chondrosarcoma Tumor cells .a 4074 to 4804 1 to 724       724/883
(81 %)
15 diff
(98.4 %id)
BG818453 anaplastic oligodendroglioma with 1p/19qloss, brain .a 4079 to 4772 1 to 693       693/693
(100 %)
4 diff
(99.5 %id)
TI_1241109867   .a 4168 to 5207 1038 to 2       1037/1211
(85 %)
29 diff
(97.7 %id)
BC032750 Testis, embryonal carcinoma .a 4174 to 6671 198 to 2695   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2499/2695
(92 %)
7 diff
(99.8 %id)
BM463481 embryonal carcinoma, cell line, testis .a 4174 to 4945 187 to 961       776/970
(80 %)
24 diff
(97.6 %id)
BC013285 Brain, neuroblastoma .a 4201 to 6671 1 to 2471   available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2471/2471
(100 %)
1 diff
(100.0 %id)
DA900808   .a 4206 to 4887 2 to 682   capped   681/682
(99 %)
5 diff
(99.3 %id)
BG385882 adenocarcinoma cell line, colon .a 4243 to 4960 1 to 721       721/722
(99 %)
14 diff
(98.1 %id)
CF131278 Chondrosarcoma Lung Metastasis cell lines, lung .a 4339 to 4973 1 to 635       635/635
(100 %)
0 diff
(100 %id)
TI_159676347   .a 4339 to 5374 44 to 1065       1022/1051
(97 %)
28 diff
(97.4 %id)
BE781181 eye, retinoblastoma .a 4357 to 5066 1 to 707       707/710
(99 %)
12 diff
(98.4 %id)
CA487843   .a 4468 to 5321 1 to 862       862/863
(99 %)
11 diff
(98.8 %id)
BQ430425 melanotic melanoma, skin .a 4483 to 5237 50 to 808       759/915
(82 %)
17 diff
(98.2 %id)
BM804167 eye, retinoblastoma .a 4538 to 5452 1 to 919       919/1073
(85 %)
23 diff
(97.9 %id)
BM466042 embryonal carcinoma, cell line, testis .a 4571 to 5415 1 to 846       846/1131
(74 %)
12 diff
(99.0 %id)
AU123667   .a 4628 to 5328 2 to 700   capped   699/699
(100 %)
6 diff
(99.2 %id)
BF529346 anaplastic oligodendroglioma with 1p/19qloss, brain .a 4702 to 5497 1 to 785       785/971
(80 %)
35 diff
(96.4 %id)
BQ949538 large cell carcinoma, lung .a 4703 to 5490 1 to 790       790/794
(99 %)
11 diff
(98.7 %id)
DA906555   .a 4759 to 5318 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BU186466 large cell carcinoma, lung .a 4771 to 5586 1 to 824       824/850
(96 %)
20 diff
(97.7 %id)
CX762497 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 4808 to 5505 1 to 698     Submitted on the opposite strand 698/698
(100 %)
0 diff
(100 %id)
BG475655 melanotic melanoma, skin .a 4836 to 5704 1 to 867       872/868
(100 %)
31 diff
(96.5 %id)
BC004497 Skin, melanotic melanoma. .a 4837 to 6671 1 to 1835   available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1835/1835
(100 %)
0 diff
(100 %id)
BG475971 melanotic melanoma, skin .a 4841 to 5711 1 to 879       879/880
(99 %)
28 diff
(96.9 %id)
BG326671 Kidney, renal cell adenocarcinoma .a 4843 to 5543 1 to 695       695/1045
(66 %)
16 diff
(98.5 %id)
CR604265 Neuroblastoma Cot 25-normalized .a 4844 to 6656 1 to 1813       1813/1813
(100 %)
0 diff
(100 %id)
AL523846 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 4844 to 5784 1 to 934   fully sequenced,   934/934
(100 %)
9 diff
(99.1 %id)
BU190764 ductal carcinoma, cell line, Pancreas .a 4850 to 5725 1 to 886       886/1040
(85 %)
29 diff
(97.3 %id)
BQ691605 ductal carcinoma, cell line, Pancreas .a 4850 to 5713 1 to 878       878/887
(98 %)
16 diff
(98.2 %id)
BE727387 melanotic melanoma, skin .a 4855 to 5631 1 to 767       767/1010
(75 %)
30 diff
(97.1 %id)
CN419353 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4857 to 5617 1 to 761       761/761
(100 %)
0 diff
(100 %id)
AW411101 muscle, rhabdomyosarcoma .a 4857 to 5399 9 to 551     Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 543/551
(98 %)
7 diff
(98.8 %id)
BE729596 melanotic melanoma, skin .a 4858 to 5632 1 to 772       772/781
(98 %)
18 diff
(97.7 %id)
BQ431474 eye, retinoblastoma .a 4860 to 5743 1 to 901       901/957
(94 %)
22 diff
(97.8 %id)
DA141796 alzheimer cortex .a 4863 to 5407 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BE019070 muscle, rhabdomyosarcoma .a 4876 to 5475 1 to 600       600/600
(100 %)
0 diff
(100 %id)
TI_1241111771   .a 4889 to 5520 636 to 7       630/636
(99 %)
0 diff
(100 %id)
AW373565 breast .a 4907 to 5523 1 to 617       617/617
(100 %)
2 diff
(99.7 %id)
AW373570 breast .a 4907 to 5523 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
BF205745 muscle, rhabdomyosarcoma .a 4926 to 5532 1 to 603       603/956
(63 %)
7 diff
(99.3 %id)
BF305039 muscle, rhabdomyosarcoma .a 4926 to 5684 1 to 752       752/850
(88 %)
16 diff
(98.2 %id)
BF306614 muscle, rhabdomyosarcoma .a 4926 to 5674 1 to 733       735/768
(95 %)
21 diff
(97.3 %id)
BF305611 muscle, rhabdomyosarcoma .a 4926 to 5632 1 to 699       699/850
(82 %)
10 diff
(98.9 %id)
BG828521 muscle, rhabdomyosarcoma .a 4926 to 5727 1 to 810       810/982
(82 %)
21 diff
(97.9 %id)
BI114371 muscle, rhabdomyosarcoma .a 4926 to 5750 1 to 835       835/932
(89 %)
36 diff
(96.2 %id)
TI_1241111755   .a 4928 to 5485 561 to 3       559/561
(99 %)
1 diff
(99.9 %id)
BU181950 eye, retinoblastoma .a 4932 to 5765 1 to 842       842/845
(99 %)
21 diff
(97.6 %id)
BE019305 muscle, rhabdomyosarcoma .a 4936 to 5541 1 to 606       606/606
(100 %)
6 diff
(99.1 %id)
TI_1241109861   .a 4966 to 6023 1090 to 24       1067/1319
(80 %)
21 diff
(98.5 %id)
BM008833 adenocarcinoma, Pancreas .a 5026 to 5805 1 to 779       779/779
(100 %)
2 diff
(99.8 %id)
TI_59386550   .a 5027 to 5805 103 to 880       778/778
(100 %)
1 diff
(99.9 %id)
BE616159 adenocarcinoma, Pancreas .a 5046 to 5829 1 to 788       788/865
(91 %)
38 diff
(95.7 %id)
BQ224767 melanotic melanoma, skin .a 5055 to 5879 1 to 832       832/847
(98 %)
13 diff
(98.5 %id)
TI_1241109847   .a 5081 to 5539 476 to 18       454/480
(94 %)
8 diff
(98.4 %id)
BF933102 nervous_tumor .a 5115 to 5499 431 to 47     Submitted on the opposite strand 385/431
(89 %)
0 diff
(100 %id)
BQ918204 large cell carcinoma, lung .a 5139 to 6020 1 to 888       888/933
(95 %)
14 diff
(98.5 %id)
TI_1241109853   .a 5141 to 6329 1203 to 16       1188/1305
(91 %)
18 diff
(98.7 %id)
DR759805 embryonic stem .a 5141 to 5888 7 to 754       750/754
(99 %)
6 diff
(99.3 %id)
AK026578   .a 5144 to 6671 1 to 1529   available from FLJ, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1529/1529
(100 %)
3 diff
(99.9 %id)
CX755645 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 5152 to 5900 1 to 749     Submitted on the opposite strand 749/749
(100 %)
4 diff
(99.5 %id)
BU177398 melanotic melanoma, skin .a 5161 to 5889 1 to 737       737/936
(78 %)
9 diff
(99.1 %id)
BM725023 eye, fetal eye .a 5170 to 5549 1 to 381     Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 381/381
(100 %)
1 diff
(99.8 %id)
CD107709 brain, Pituitary .a 5182 to 5976 1 to 800       800/865
(92 %)
7 diff
(99.2 %id)
BF794902 lymph, lymphoma, cell line .a 5217 to 5898 1 to 678       678/691
(98 %)
17 diff
(97.6 %id)
BE275670 melanotic melanoma, skin .a 5219 to 5885 1 to 662       662/674
(98 %)
9 diff
(98.7 %id)
BE274949 melanotic melanoma, skin .a 5219 to 6005 1 to 788       788/856
(92 %)
17 diff
(98.1 %id)
BF663214 B-cells, primary B-cells from tonsils (cell line) .a 5241 to 5953 1 to 713       713/939
(75 %)
15 diff
(98.5 %id)
BP377700 uterus .a 5241 to 5823 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BG679482 skin, squamous cell carcinoma .a 5248 to 6142 1 to 899       902/908
(99 %)
17 diff
(98.2 %id)
DA077985 cerebellum .a 5312 to 5835 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
BX372263   .a 5328 to 6216 885 to 1       885/885
(100 %)
6 diff
(99.4 %id)
BU172207 adenocarcinoma, Pancreas .a 5387 to 6228 1 to 844       844/929
(90 %)
24 diff
(97.5 %id)
BE392373 endometrium, adenocarcinoma cell line, uterus .a 5441 to 6070 1 to 628       628/629
(99 %)
8 diff
(98.8 %id)
CN347304 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 5454 to 6209 1 to 757       757/757
(100 %)
3 diff
(99.7 %id)
BQ677575 melanotic melanoma, cell line, skin .a 5458 to 6309 1 to 856       856/865
(98 %)
13 diff
(98.5 %id)
TI_1241108497   .a 5490 to 6562 1144 to 85     Submitted on the opposite strand 1060/1222
(86 %)
17 diff
(98.7 %id)
TI_1241108501   .a 5529 to 6566 1110 to 84     Submitted on the opposite strand 1027/1221
(84 %)
15 diff
(98.8 %id)
CR995888 T-Lymphocytes .a 5565 to 6364 1 to 799       799/801
(99 %)
2 diff
(99.8 %id)
BY795856 eye .a 5606 to 6238 1 to 633       633/633
(100 %)
0 diff
(100 %id)
AL527124 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 5635 to 6665 1022 to 1       1022/1037
(98 %)
18 diff
(98.3 %id)
AL523845 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 5754 to 6656 895 to 1   fully sequenced,   895/895
(100 %)
13 diff
(98.6 %id)
BQ070508 brain, neuroblastoma, cell line .a 5763 to 6602 1 to 858       858/1051
(81 %)
22 diff
(98.0 %id)
BG389114 embryonal carcinoma, cell line, testis .a 5770 to 6590 1 to 816       816/1121
(72 %)
16 diff
(98.6 %id)
BG687323 lung, mucoepidermoid carcinoma .a 5780 to 6464 1 to 688       688/688
(100 %)
5 diff
(99.3 %id)
BG492539 lung, mucoepidermoid carcinoma .a 5781 to 6574 1 to 807       807/907
(88 %)
31 diff
(96.6 %id)
BG493766 lung, mucoepidermoid carcinoma .a 5781 to 6505 1 to 728       728/729
(99 %)
6 diff
(99.2 %id)
BG527299 lung, mucoepidermoid carcinoma .a 5781 to 6394 1 to 614       614/616
(99 %)
5 diff
(99.2 %id)
BG527393 lung, mucoepidermoid carcinoma .a 5781 to 6593 1 to 808       808/808
(100 %)
8 diff
(99.1 %id)
BG528088 lung, mucoepidermoid carcinoma .a 5781 to 6516 1 to 741   AAA   741/847
(87 %)
20 diff
(97.7 %id)
BG776765 lung, mucoepidermoid carcinoma .a 5782 to 6551 1 to 772       772/772
(100 %)
9 diff
(98.9 %id)
BQ923170 epidermoid carcinoma, cell line, lung .a 5811 to 6703 899 to 1     Submitted on the opposite strand 899/899
(100 %)
11 diff
(98.8 %id)
BQ276322 carcinoma, cell line, Prostate .a 5831 to 6671 1 to 841       841/847
(99 %)
11 diff
(98.8 %id)
BU177791 melanotic melanoma, cell line, skin .a 5831 to 6671 1 to 841   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 841/841
(100 %)
0 diff
(100 %id)
BU162851 melanotic melanoma, cell line, skin .a 5831 to 6663 1 to 840   AAA   840/848
(99 %)
8 diff
(99.1 %id)
BM045997 carcinoma, cell line, Prostate .a 5840 to 6670 1 to 835       835/853
(97 %)
9 diff
(99.0 %id)
BQ946918 epidermoid carcinoma, cell line, lung .a 5853 to 6704 856 to 1     Submitted on the opposite strand 856/857
(99 %)
11 diff
(98.8 %id)
AL582249 B cells from Burkitt lymphoma .a 5877 to 6637 761 to 1       761/992
(76 %)
25 diff
(97.5 %id)
BQ183022 Knee, Osteoarthritic Cartilage .a 5887 to 6671 789 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 771/775
(99 %)
15 diff
(98.1 %id)
TI_154122700   .a 5887 to 6660 848 to 84   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 765/954
(80 %)
16 diff
(98.4 %id)
TI_154110508   .a 5899 to 6660 829 to 78   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 752/966
(77 %)
11 diff
(98.9 %id)
BQ279186 adenocarcinoma, cell line, breast .a 5905 to 6671 1 to 768   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 768/768
(100 %)
1 diff
(99.9 %id)
CA455404 adenocarcinoma, cell line, breast .a 5905 to 6671 1 to 769       769/892
(86 %)
17 diff
(98.1 %id)
BU537932 adenocarcinoma, cell line, breast .a 5910 to 6663 1 to 758   AAA   758/766
(98 %)
4 diff
(99.5 %id)
BQ354862 head_neck .a 5915 to 6367 453 to 1       453/453
(100 %)
10 diff
(97.8 %id)
BF965010 muscle (skeletal) .a 5922 to 6665 1 to 749       749/923
(81 %)
27 diff
(97.1 %id)
BM680234 eye, fetal eye .a 5927 to 6671 757 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 739/762
(96 %)
9 diff
(98.9 %id)
BE620912 large cell carcinoma, undifferentiated, lung .a 5946 to 6622 679 to 1       679/682
(99 %)
2 diff
(99.8 %id)
TI_149275481   .a 5953 to 6671 820 to 105   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 716/964
(74 %)
6 diff
(99.4 %id)
AW006988 colon .a 5959 to 6672 711 to 1       711/711
(100 %)
6 diff
(99.2 %id)
CN480031 Chondrosarcoma, Left Pubic Bone .a 5986 to 6660 692 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 674/674
(100 %)
1 diff
(99.9 %id)
AW008382 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 6022 to 6671 648 to 1       648/689
(94 %)
7 diff
(99.0 %id)
BX456827.
matches multiple genes
thymus .a 6024 to 6643 621 to 1     also hits gene SERTAD2 621/621
(100 %)
2 diff
(99.7 %id)
AW338932 adenocarcinoma, Pancreas .a 6025 to 6655 631 to 1       631/631
(100 %)
0 diff
(100 %id)
BE856718 pooled .a 6033 to 6661 631 to 4       628/631
(99 %)
6 diff
(99.1 %id)
BM931420 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6033 to 6258 1 to 226   fully sequenced, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 226/226
(100 %)
0 diff
(100 %id)
BM931459 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6033 to 6409 1 to 377   fully sequenced, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 377/377
(100 %)
0 diff
(100 %id)
BU676676 lung, Primary Lung Epithelial Cells .a 6035 to 6671 655 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 637/637
(100 %)
1 diff
(99.9 %id)
CA310531 Human Lung Epithelial cells, lung .a 6035 to 6660 644 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 626/626
(100 %)
0 diff
(100 %id)
BQ003955 Chondrosarcoma, Left Pelvis .a 6036 to 6671 654 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 636/636
(100 %)
3 diff
(99.6 %id)
CA431794 Bone, Subchondral Bone .a 6040 to 6660 639 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 621/621
(100 %)
1 diff
(99.9 %id)
W68060 heart .a 6073 to 6322 1 to 251   fully sequenced,   251/251
(100 %)
1 diff
(99.7 %id)
AL079408 testis .a 6086 to 6662 640 to 64   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 577/577
(100 %)
0 diff
(100 %id)
BQ003075 Chondrosarcoma, Left Pelvis .a 6094 to 6675 600 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 582/582
(100 %)
2 diff
(99.7 %id)
BU153428 embryonal carcinoma, cell line, testis .a 6094 to 6671 1 to 578   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 578/578
(100 %)
0 diff
(100 %id)
AA446285   .a 6095 to 6409 12 to 325   fully sequenced,   314/325
(96 %)
7 diff
(97.9 %id)
BI094325 cervix .a 6103 to 6672 1 to 570       570/585
(97 %)
1 diff
(99.9 %id)
BQ937271 epidermoid carcinoma, cell line, lung .a 6103 to 6704 611 to 1   tiling clone, Submitted on the opposite strand 611/1033
(59 %)
15 diff
(98.6 %id)
AI874349 ovary, tumor, 5 pooled (see description) .a 6105 to 6671 567 to 1       567/575
(98 %)
1 diff
(99.9 %id)
AA614335 lung, lung tumor .a 6110 to 6666 557 to 1       557/557
(100 %)
0 diff
(100 %id)
BF204114 muscle, rhabdomyosarcoma .a 6114 to 6671 1 to 555   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 555/555
(100 %)
4 diff
(99.3 %id)
AW960928   .a 6121 to 6660 550 to 11     Submitted on the opposite strand 540/550
(98 %)
6 diff
(99.0 %id)
BE046199 follicular carcinoma, thyroid .a 6124 to 6672 555 to 7       549/555
(98 %)
2 diff
(99.7 %id)
AI589544 anaplastic oligodendroglioma, brain .a 6127 to 6672 547 to 2       546/547
(99 %)
0 diff
(100 %id)
AW051578 pooled .a 6128 to 6670 542 to 1       542/546
(99 %)
14 diff
(97.5 %id)
AJ003434   .a 6146 to 6560 423 to 9       415/423
(98 %)
1 diff
(99.8 %id)
AA196209   .a 6148 to 6645 509 to 1       509/639
(79 %)
17 diff
(97.4 %id)
AA085963 colon, tumor .a 6157 to 6659 1 to 506   fully sequenced,   506/506
(100 %)
6 diff
(98.9 %id)
AW044656 pooled .a 6160 to 6670 511 to 1       511/511
(100 %)
1 diff
(99.9 %id)
DB354308   .a 6167 to 6671 504 to 1       504/506
(99 %)
5 diff
(99.1 %id)
AA158521 Pancreas .a 6172 to 6661 494 to 5       490/494
(99 %)
0 diff
(100 %id)
BE207974 muscle, rhabdomyosarcoma .a 6172 to 6457 286 to 1       286/286
(100 %)
0 diff
(100 %id)
AW971141   .a 6195 to 6672 594 to 118     Submitted on the opposite strand 477/594
(80 %)
3 diff
(99.5 %id)
BE207823 muscle, rhabdomyosarcoma .a 6196 to 6457 262 to 1       262/262
(100 %)
0 diff
(100 %id)
BM675487 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6197 to 6671 493 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 475/475
(100 %)
0 diff
(100 %id)
BJ993046 hepatoblastoma .a 6206 to 6635 430 to 1       430/430
(100 %)
0 diff
(100 %id)
BF439374 pooled .a 6206 to 6670 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AW771819 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 6209 to 6671 460 to 1       460/478
(96 %)
10 diff
(98.0 %id)
H55820 liver and spleen .a 6214 to 6454 1 to 246   fully sequenced,   246/246
(100 %)
2 diff
(99.2 %id)
BX119275 liver and spleen .a 6215 to 6671 1 to 457   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 457/457
(100 %)
0 diff
(100 %id)
AA648710 germinal center B cell .a 6218 to 6664 459 to 12   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 448/448
(100 %)
2 diff
(99.6 %id)
AA461204.
matches multiple genes
  .a 6219 to 6667 451 to 3     also hits gene HAPLN1 449/451
(99 %)
0 diff
(100 %id)
AA663320   .a 6220 to 6661 441 to 1       441/441
(100 %)
4 diff
(99.1 %id)
AA040227 heart .a 6221 to 6409 1 to 191   fully sequenced,   191/191
(100 %)
1 diff
(99.5 %id)
DB508819 testis .a 6222 to 6660 1 to 445     Submitted on the opposite strand 443/446
(99 %)
18 diff
(96.0 %id)
AA515301 colon .a 6226 to 6671 446 to 1       446/446
(100 %)
0 diff
(100 %id)
BU607474 Human Lung Epithelial cells, lung .a 6226 to 6671 464 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 446/464
(96 %)
2 diff
(99.6 %id)
W23025 eye, retina .a 6226 to 6637 417 to 1       417/668
(62 %)
10 diff
(98.6 %id)
FN071005 breast carcinoma .a 6227 to 6310 83 to 1     Submitted on the opposite strand 83/84
(98 %)
1 diff
(98.9 %id)
BG202373   .a 6230 to 6654 1 to 426       426/426
(100 %)
2 diff
(99.6 %id)
AA827373 Kidney, kidney tumor .a 6233 to 6645 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AI041904 senescent fibroblast .a 6240 to 6667 431 to 4       428/431
(99 %)
0 diff
(100 %id)
AA722811 heart .a 6241 to 6672 434 to 3       432/434
(99 %)
0 diff
(100 %id)
AI207332 Kidney .a 6251 to 6617 371 to 5       367/371
(98 %)
0 diff
(100 %id)
AA776975 heart .a 6254 to 6665 411 to 1       411/411
(100 %)
1 diff
(99.8 %id)
AA669189 lung .a 6262 to 6672 411 to 1       411/411
(100 %)
0 diff
(100 %id)
BF941158 dorsal root ganglia .a 6262 to 6665 402 to 1       402/402
(100 %)
12 diff
(97.1 %id)
AA483819 colon .a 6263 to 6672 409 to 1       409/409
(100 %)
4 diff
(99.1 %id)
AW057791 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 6272 to 6672 401 to 1       401/401
(100 %)
0 diff
(100 %id)
AA804954 colon .a 6276 to 6671 394 to 1       394/394
(100 %)
3 diff
(99.3 %id)
AA747858 pooled germ cell tumors .a 6282 to 6671 390 to 1       390/390
(100 %)
1 diff
(99.8 %id)
AA515376 colon .a 6287 to 6672 386 to 1       386/386
(100 %)
2 diff
(99.5 %id)
AA085964 colon, tumor .a 6288 to 6672 386 to 2   fully sequenced,   385/386
(99 %)
0 diff
(100 %id)
AI033403 liver and spleen .a 6288 to 6671 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AA721087 germinal center B cell .a 6289 to 6660 420 to 49   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 372/372
(100 %)
0 diff
(100 %id)
BG057038 anaplastic oligodendroglioma, brain .a 6289 to 6672 384 to 1       384/384
(100 %)
0 diff
(100 %id)
W68061 heart .a 6292 to 6662 370 to 1   fully sequenced,   370/370
(100 %)
1 diff
(99.8 %id)
AI476479 colon, moderately-differentiated adenocarcinoma .a 6295 to 6672 384 to 7       378/384
(98 %)
0 diff
(100 %id)
AW072762 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .a 6295 to 6677 397 to 14   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 384/384
(100 %)
32 diff
(91.7 %id)
CA431202 cell lines, Enchondroma .a 6306 to 6671 385 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 367/367
(100 %)
1 diff
(99.8 %id)
AW971016   .a 6310 to 6671 486 to 125   AAA Submitted on the opposite strand 362/398
(90 %)
1 diff
(99.8 %id)
AA503409 Prostate .a 6310 to 6672 369 to 7       363/374
(97 %)
0 diff
(100 %id)
AA527756 Prostate .a 6310 to 6672 369 to 7       363/380
(95 %)
0 diff
(100 %id)
AA873227 2 pooled tumors (clear cell type), Kidney .a 6311 to 6672 364 to 3       362/364
(99 %)
0 diff
(100 %id)
BM473340 leiomyosarcoma, uterus .a 6319 to 6671 31 to 383   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 353/383
(92 %)
6 diff
(98.5 %id)
AA251599 germinal center B cell .a 6321 to 6668 1 to 348       348/348
(100 %)
0 diff
(100 %id)
AW006785 colon .a 6324 to 6661 342 to 5       338/342
(98 %)
0 diff
(100 %id)
BM805031 ovary (pool of 3) .a 6327 to 6671 24 to 368   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 345/368
(93 %)
7 diff
(98.1 %id)
AW411102 muscle, rhabdomyosarcoma .a 6336 to 6671 361 to 26   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 336/336
(100 %)
1 diff
(99.8 %id)
FN072815 breast carcinoma .a 6338 to 6427 90 to 1     Submitted on the opposite strand 90/92
(97 %)
5 diff
(94.6 %id)
AJ003435   .a 6338 to 6673 345 to 10       336/345
(97 %)
0 diff
(100 %id)
AA039862 heart .a 6348 to 6672 332 to 4   fully sequenced,   329/332
(99 %)
1 diff
(99.7 %id)
AA446010   .a 6348 to 6672 328 to 4   fully sequenced,   325/328
(99 %)
0 diff
(100 %id)
BM675590 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6348 to 6671 342 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 324/324
(100 %)
0 diff
(100 %id)
AA659734 normal prostate, Prostate .a 6358 to 6680 327 to 5       323/327
(98 %)
0 diff
(100 %id)
AI913764 colon .a 6364 to 6672 310 to 2       309/310
(99 %)
0 diff
(100 %id)
T78908 liver and spleen .a 6368 to 6628 261 to 2       260/389
(66 %)
0 diff
(100 %id)
AI225198 lymph node, lymphoma, follicular mixed small and largecell .a 6377 to 6672 301 to 6       296/302
(98 %)
0 diff
(100 %id)
AI687381 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 6379 to 6671 306 to 14   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 293/293
(100 %)
0 diff
(100 %id)
AA502296 colon .a 6387 to 6671 285 to 1       285/285
(100 %)
0 diff
(100 %id)
AA721069 germinal center B cell .a 6392 to 6660 317 to 49   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 269/269
(100 %)
0 diff
(100 %id)
AA631285 colon, colon tumor RER+ .a 6397 to 6672 282 to 7       276/282
(97 %)
0 diff
(100 %id)
AI446697 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 6421 to 6672 252 to 1       252/252
(100 %)
0 diff
(100 %id)
H55821 liver and spleen .a 6424 to 6673 251 to 1   fully sequenced,   251/251
(100 %)
4 diff
(98.5 %id)
C00395   .a 6462 to 6671 1 to 211       211/211
(100 %)
2 diff
(99.1 %id)
C01191   .a 6487 to 6671 47 to 234       188/234
(80 %)
6 diff
(97.5 %id)
BE223087 brain, oligodendroglioma .a 6531 to 6672 145 to 4       142/145
(97 %)
0 diff
(100 %id)
CA429472 Cell Line, Chondrosarcoma .a 6558 to 6671 130 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 112/112
(100 %)
2 diff
(98.3 %id)
BE882735 leiomyosarcoma, uterus .a 6569 to 6680 1 to 111       111/115
(96 %)
2 diff
(98.3 %id)
DA115806 cerebellum .b 1 to 561 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
CN419358 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 29 to 607 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
DA933721 Spleen .b 130 to 696 2 to 568   tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
AW817800 stomach .b 271 to 740 1 to 469       469/480
(97 %)
3 diff
(99.4 %id)
AK127239 hippocampus .b 289 to 4362 1 to 4074 N218S tiling clone, available from FLJ,   4074/4074
(100 %)
6 diff
(99.9 %id)
DA314328 hippocampus .b 290 to 847 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA183393 amygdala .b 483 to 1037 2 to 556   capped   555/555
(100 %)
3 diff
(99.5 %id)
CN315249 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 628 to 1164 12 to 549   tiling clone,   538/549
(97 %)
6 diff
(99.0 %id)
BF376050 testis_normal .b 683 to 812 152 to 22       131/152
(86 %)
0 diff
(100 %id)
BE709962 head_neck .b 813 to 1269 461 to 5   tiling clone,   457/461
(99 %)
0 diff
(100 %id)
BE709946 head_neck .b 823 to 1269 448 to 2       447/448
(99 %)
0 diff
(100 %id)
DA858649 placenta .b 957 to 1531 2 to 576   tiling clone, capped   575/575
(100 %)
3 diff
(99.5 %id)
DB308671 hippocampus .b 3821 to 4362 542 to 1       542/542
(100 %)
1 diff
(99.9 %id)
AB005543   .c 1 to 2536 1 to 2536 exact tiling clone,   2536/2536
(100 %)
2 diff
(100.0 %id)
DA732979   .c 2057 to 2624 2 to 569   tiling clone, capped   568/568
(100 %)
7 diff
(98.8 %id)
DB364693   .c 3415 to 3855 441 to 1   tiling clone,   441/443
(99 %)
1 diff
(99.8 %id)
AW841785 colon_normal .d 1 to 270 270 to 1   tiling clone,   270/270
(100 %)
0 diff
(100 %id)
DB284666 uterus .d 54 to 603 2 to 551   tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
AK126313 trachea .d 518 to 5109 1 to 4590 exact tiling clone, available from FLJ,   4590/4590
(100 %)
3 diff
(100.0 %id)
DB215847 trachea .d 519 to 1076 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA225611 brain .d 599 to 1161 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
DB089373 testis .d 677 to 1233 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA333581 hippocampus .d 678 to 1270 2 to 594   tiling clone, capped   593/593
(100 %)
1 diff
(99.9 %id)
BX471976   .d 854 to 1538 1 to 684       684/684
(100 %)
1 diff
(99.9 %id)
CV316377 testis_normal .d 903 to 1180 1 to 283       283/283
(100 %)
19 diff
(93.3 %id)
AI865648 normal prostate, Prostate .d 994 to 1491 1 to 502     Submitted on the opposite strand 502/502
(100 %)
14 diff
(97.3 %id)
DA231078 brain .d 1010 to 1541 2 to 533   capped   532/532
(100 %)
3 diff
(99.5 %id)
DA239459 brain .d 1010 to 1598 2 to 590   capped   589/597
(98 %)
3 diff
(99.5 %id)
DA394759 thalamus .d 1166 to 1766 2 to 602   capped   601/601
(100 %)
1 diff
(99.9 %id)
DB290580 uterus .d 1231 to 1791 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DB065510 testis .d 1296 to 1837 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
DB055563 testis .d 1418 to 1999 2 to 588   capped   587/587
(100 %)
6 diff
(99.0 %id)
AJ003454   .d 2888 to 3458 10 to 587       578/587
(98 %)
18 diff
(97.0 %id)
AJ003436   .d 2952 to 3398 1 to 449       449/449
(100 %)
14 diff
(96.9 %id)
CT001023 T-Lymphocytes .d 2989 to 3597 1 to 611       611/611
(100 %)
2 diff
(99.7 %id)
DA961758 Spleen .d 2995 to 3532 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
BE840641 prostate_normal .d 3265 to 3449 1 to 185       185/196
(94 %)
7 diff
(96.5 %id)
BE840604 prostate_normal .d 3267 to 3449 1 to 182       182/186
(97 %)
8 diff
(95.7 %id)
BE840688 prostate_normal .d 3271 to 3449 16 to 194       179/198
(90 %)
4 diff
(98.0 %id)
BM928243 hepatocellular carcinoma, cell line, Liver .d 4343 to 5250 8 to 925       918/1125
(81 %)
27 diff
(97.6 %id)
DB352711 uterus .d 4558 to 5109 552 to 1       552/552
(100 %)
3 diff
(99.5 %id)
DB349070 trachea .d 4563 to 5109 547 to 1       547/547
(100 %)
0 diff
(100 %id)
DA959184 Spleen .d 4756 to 5303 2 to 549   tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
BU536509 mixed (pool of 40 RNAs) .d 4904 to 5146 1 to 243   tiling clone,   243/279
(87 %)
2 diff
(99.3 %id)
BF840028 head_neck .e 1 to 208 1 to 206   tiling clone,   206/206
(100 %)
7 diff
(96.7 %id)
DA875101 Prostate .e 130 to 699 2 to 570   tiling clone, to resequence, capped   569/569
(100 %)
1 diff
(99.9 %id)
DB330103 Prostate .e 1388 to 1929 542 to 1   tiling clone, to resequence,   542/543
(99 %)
2 diff
(99.7 %id)
DB269328 uterus .f 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
BF059717 pooled germ cell tumors .f 549 to 1129 581 to 1   tiling clone,   581/581
(100 %)
9 diff
(98.5 %id)
AW296151   .f 711 to 1128 435 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 418/418
(100 %)
0 diff
(100 %id)
BF510331   .f 711 to 1128 435 to 18   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 418/418
(100 %)
0 diff
(100 %id)
AI962557 pooled germ cell tumors .f 729 to 1129 408 to 8       401/408
(98 %)
0 diff
(100 %id)
BE762754 nervous_tumor .f 1083 to 1182 16 to 114   tiling clone,   99/114
(86 %)
6 diff
(94.8 %id)
CA502806 Human Lung Epithelial cells, lung .g 1 to 727 744 to 19 L5X S13L D15T H16I K17N ... tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 726/726
(100 %)
1 diff
(99.9 %id)
BQ446259 Knee, Osteoarthritic Cartilage .g 20 to 727 725 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 707/707
(100 %)
1 diff
(99.9 %id)
BM914448 Spleen .h 1 to 709 1 to 709 E136X tiling clone,   777/993
(78 %)
21 diff
(97.9 %id)
BG912602 anaplastic oligodendroglioma with 1p/19qloss, brain .i 1 to 586 16 to 580   tiling clone,   565/664
(85 %)
33 diff
(95.1 %id)
BE763185 nervous_tumor .i 540 to 815 287 to 13   tiling clone,   275/287
(95 %)
0 diff
(100 %id)
AA971137 pooled .i 726 to 1160 435 to 1   tiling clone,   435/436
(99 %)
1 diff
(99.8 %id)
AI699416 pooled .i 752 to 1160 406 to 1       406/406
(100 %)
10 diff
(97.6 %id)
BE831164 marrow .i 898 to 1261 1 to 364   tiling clone,   364/364
(100 %)
10 diff
(97.3 %id)
AK022303 mammary gland .j-u 1 to 1760 2 to 1762 exact tiling clone, available from FLJ,   1762/1762
(100 %)
8 diff
(99.6 %id)
AU121918 mammary gland .j-u 1 to 548 2 to 549   capped   548/552
(99 %)
3 diff
(99.5 %id)
AI355625 esophagus, squamous cell carcinoma .j-u 285 to 706 422 to 1   tiling clone,   422/422
(100 %)
3 diff
(99.3 %id)
BF982490 duodenal adenocarcinoma, cell line, small intestine .j-u 560 to 1270 1 to 707   tiling clone,   707/978
(72 %)
42 diff
(95.8 %id)
AU147647 mammary gland .j-u 1194 to 1760 567 to 1       567/567
(100 %)
3 diff
(99.5 %id)
CB153959 brain .k 1 to 554 1 to 554 exact tiling clone,   554/554
(100 %)
1 diff
(99.9 %id)
DB068266 testis .l 1 to 555 2 to 556   tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
DA109147 cerebellum .l 497 to 1073 2 to 579 V95C V96G R97A M98H L99A ... tiling clone, capped   578/579
(99 %)
2 diff
(99.7 %id)
DA513421 brain .m 1 to 569 2 to 570 exact tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
DB508289.
matches multiple genes
testis .n-u 1 to 416 416 to 1   tiling clone, also hits gene MCM3APAS 416/418
(99 %)
0 diff
(100 %id)
DB050398 testis .n-u 17 to 331 2 to 316   capped   315/315
(100 %)
0 diff
(100 %id)
AA702534 liver and spleen .n-u 139 to 650 512 to 1       512/512
(100 %)
0 diff
(100 %id)
AA701970 liver and spleen .n-u 168 to 650 483 to 1       483/483
(100 %)
0 diff
(100 %id)
DB289756 uterus .n-u 193 to 779 2 to 586   to resequence, capped   585/585
(100 %)
1 diff
(99.9 %id)
BX099618   .n-u 213 to 663 1 to 455   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 455/458
(99 %)
7 diff
(98.5 %id)
AI692285 carcinoid, lung .n-u 213 to 655 443 to 1       443/443
(100 %)
6 diff
(98.7 %id)
BU078292 Pancreas, Purified pancreatic islet .n-u 238 to 541 1 to 305   fully sequenced,   305/305
(100 %)
3 diff
(99.1 %id)
AI126148   .n-u 246 to 653 408 to 1       408/408
(100 %)
1 diff
(99.8 %id)
AA573177 breast .n-u 303 to 647 345 to 1       345/345
(100 %)
2 diff
(99.5 %id)
CR742772   .n-u 366 to 971 1 to 606   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 606/608
(99 %)
1 diff
(99.9 %id)
AI638162 pooled germ cell tumors .n-u 407 to 958 552 to 1       552/552
(100 %)
1 diff
(99.9 %id)
BU078042 Pancreas, Purified pancreatic islet .n-u 511 to 957 450 to 1   fully sequenced,   450/450
(100 %)
7 diff
(98.5 %id)
CN479453 Chondrosarcoma, Left Pubic Bone .n-u 520 to 663 148 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 143/148
(96 %)
0 diff
(100 %id)
BE504104 carcinoid, lung .n-u 545 to 957 417 to 1       417/417
(100 %)
4 diff
(99.1 %id)
BF110566 carcinoid, lung .n-u 546 to 961 420 to 1       420/420
(100 %)
2 diff
(99.6 %id)
BF110968 carcinoid, lung .n-u 546 to 961 422 to 1       422/422
(100 %)
6 diff
(98.6 %id)
BF436206 pooled .n-u 601 to 962 362 to 1       362/362
(100 %)
0 diff
(100 %id)
CN255339 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n-u 683 to 1319 1 to 637   tiling clone,   637/637
(100 %)
3 diff
(99.6 %id)
AA476353   .n-u 774 to 962 189 to 1       189/189
(100 %)
0 diff
(100 %id)
AA461384.
matches multiple genes
  .n-u 852 to 1443 1 to 592   tiling clone, also hits gene shorrarbo 592/592
(100 %)
1 diff
(99.9 %id)
AJ003425   .n-u 1427 to 1934 10 to 517   tiling clone,   508/517
(98 %)
6 diff
(98.9 %id)
AI934177 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .n-u 1637 to 2002 371 to 3   tiling clone,   369/371
(99 %)
0 diff
(100 %id)
CB994617 placenta, pre-eclamptic placenta .n-u 1807 to 2257 29 to 479 R67S     451/482
(93 %)
2 diff
(99.6 %id)
CB996172 placenta, pre-eclamptic placenta .n-u 1807 to 2542 29 to 766 R67S tiling clone,   738/766
(96 %)
6 diff
(99.3 %id)
CB995585 placenta, pre-eclamptic placenta .n-u 1807 to 2472 29 to 703 R67S     675/833
(81 %)
27 diff
(96.8 %id)
DB277629 uterus .n-u 1933 to 2491 2 to 561   tiling clone, capped   560/560
(100 %)
3 diff
(99.5 %id)
DB352967 uterus .n-u 3214 to 3755 543 to 1   tiling clone, to resequence,   543/543
(100 %)
2 diff
(99.7 %id)
AI016596   .n-u 3344 to 3755 424 to 14   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 411/411
(100 %)
1 diff
(99.8 %id)
CN315169 embryonic stem cells, cell lines H1, H7, andH9 .o-u 1 to 692 1 to 694 K44* tiling clone,   694/694
(100 %)
8 diff
(98.9 %id)
BU631771 cell lines, Chondrosarcoma .o-u 351 to 1033 702 to 19 H35X T36H Q37P P38A H39P ... tiling clone, AAA   684/684
(100 %)
2 diff
(99.8 %id)
DA403387 thalamus .o-u 961 to 1517 2 to 558   tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
BF901584 marrow .o-u 1090 to 1592 67 to 568   tiling clone,   502/603
(83 %)
6 diff
(99.1 %id)
DR422969 eye, Pterygium .p-u 1 to 688 1 to 688   tiling clone,   688/688
(100 %)
2 diff
(99.8 %id)
BF760343 colon .p-u 385 to 773 394 to 6   tiling clone, Submitted on the opposite strand 389/394
(98 %)
0 diff
(100 %id)
TI_227715459   .p-u 409 to 1450 1123 to 85 exact tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1039/1051
(98 %)
42 diff
(96.1 %id)
CB529678 Aveolar Macrophage, lung .p-u 708 to 1450 761 to 20 exact AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 742/742
(100 %)
2 diff
(99.8 %id)
CD366595 Alveolar Macrophage, lung .p-u 722 to 1450 748 to 20 exact AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 729/729
(100 %)
1 diff
(99.9 %id)
AA527431 colon .p-u 847 to 1461 617 to 3 exact tiling clone,   615/618
(99 %)
0 diff
(100 %id)
BX090537 colon .p-u 851 to 1454 1 to 604 exact     604/604
(100 %)
0 diff
(100 %id)
AI952837 pooled germ cell tumors .p-u 1099 to 1450 352 to 1       352/352
(100 %)
0 diff
(100 %id)
AA558994 breast .p-u 1192 to 1450 282 to 24   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 259/259
(100 %)
0 diff
(100 %id)
N72323 liver and spleen .q-u 1 to 179 1 to 179   tiling clone,   179/179
(100 %)
4 diff
(97.8 %id)
CR742266 liver and spleen .q-u 3 to 645 1 to 643 exact tiling clone,   643/643
(100 %)
2 diff
(99.7 %id)
H56543 liver and spleen .q-u 325 to 718 1 to 398   tiling clone,   398/405
(98 %)
13 diff
(96.8 %id)
N52824 liver and spleen .q-u 625 to 1127 525 to 1   tiling clone,   525/525
(100 %)
14 diff
(97.4 %id)
L25497   .q-u 666 to 828 165 to 1   tiling clone,   165/165
(100 %)
4 diff
(97.6 %id)
H56544 liver and spleen .q-u 845 to 1082 243 to 1       243/243
(100 %)
8 diff
(96.8 %id)
M78782   .r-u 364 to 778 1 to 414   tiling clone,   414/418
(99 %)
5 diff
(98.9 %id)
BU781707 insulinoma, Pancreas .s 1 to 254 3 to 256 exact tiling clone, fully sequenced,   254/256
(99 %)
5 diff
(98.1 %id)
BU784064 insulinoma, Pancreas .s 6 to 483 8 to 485 exact fully sequenced, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 478/485
(98 %)
6 diff
(98.8 %id)
BU786841 insulinoma, Pancreas .s 224 to 621 398 to 1   tiling clone, fully sequenced,   398/398
(100 %)
1 diff
(99.8 %id)
BU783795 insulinoma, Pancreas .s 422 to 641 245 to 26   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 220/220
(100 %)
0 diff
(100 %id)
BP284716 bone marrow .t 1 to 585 1 to 583 exact tiling clone,   583/583
(100 %)
3 diff
(99.5 %id)
BF370037 prostate_normal .u-u 1 to 543 1 to 545 M15R S22A L23W E28D L29R ... tiling clone,   545/553
(98 %)
24 diff
(95.7 %id)
BF089952 marrow .va-u 1 to 212 9 to 219 E9S L10* tiling clone,   211/219
(96 %)
6 diff
(97.3 %id)
CV364494 head_normal .va-u 10 to 314 1 to 308   tiling clone,   308/308
(100 %)
17 diff
(94.5 %id)
BQ378899 uterus_tumor .vc 1 to 259 266 to 8 exact tiling clone,   259/266
(97 %)
0 diff
(100 %id)
DB443361.
matches multiple genes
testis AS.l 3 to 453 1 to 452 exact   also hits gene MCM3APAS 452/452
(100 %)
2 diff
(99.6 %id)
AK095181 substantia nigra Gene MCM3AP, variant not shown       available from FLJ, This clone was ignored    
CV325444 head_neck Gene MCM3AP, variant not shown         Submitted on the opposite strand    
DB355396 whole embryo, mainly head Gene MCM3AP, variant not shown         Suspected internal deletion, this clone was ignored    
BF316700 brain, neuroblastoma Gene MCM3AP, variant not shown              
219 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n-u, .o-u, .p-u, .q-u, .r-u, .s, .t, .u-u, .va-u, .vb-u, .vc Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI